← Back to Patent Explorer
US4235962A Expired / Lapsed US ⏱️ 0.0 years remaining

Combination kit for transaminase assay of a body fluid

Assignee: Dow Chemical Co
•
Filing: 1978-08-21
•
Granted: 1980-11-25
•
Expires: 1998-08-21
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A kit for the determination of transaminase present in body fluid having a first reagent containing aspartate, a second reagent containing alanine, and a third reagent containing 2-oxoglutarate substrate in combination with a secondary reaction system containing reduced nicotinamide adenine dineucleotide.

Inventors

  • 👤 James S. Sanderson

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-08 05:36
CPC Classifications
C; C12; C12Q; C12Q1/00; C12Q1/48; C12Q1/52; Y; Y10; Y10S; Y10S435/00; Y10S435/81

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 166 words
A reagent kit for the determination of transaminase present in a body fluid comprising a first reagent containing aspartate, a second reagent containing alanine, and a third reagent containing 2-oxoglutarate, reduced nicotinamide adenine dinucleotide (NADH), malate dehydrogenase (MDH), and lactate dehydrogenase (LDH) wherein the amounts of each reagent used are sufficient to provide, upon direct mixing of said first reagent with said third reagent, a resulting mixture containing at least 35 millimolar concentration of aspartate, from about 0.2 to about 35 millimolar concentration of 2-oxoglutarate, from about 0.5 to about 5 millimolar concentration of reduced NADH, at least 175 units/liter of LDH and at least 140 units/liter of MDH and upon direct mixing of, said second reagent with said third reagent, to provide a resulting mixture containing at least 130 millimolar alanine, from about 0.2 to about 35 millimolar concentration of 2-oxoglutarate, from about 0.5 to about 5 millimolar concentration of reduced NADH, at least 175 units/liter of LDH and at least 140 units/liter of MDH.
Claim 2
Dependent Claim 166 words
A reagent kit for the determination of transaminase present in a body fluid comprising a first reagent containing aspartate, a second reagent containing alanine, and a third reagent containing 2-oxoglutarate, reduced nicotinamide adenine dinucleotide (NADH), malate dehydrogenase (MDH), and lactate dehydrogenase (LDH) wherein the amounts of each reagent used are sufficient to provide, upon direct mixing of said first reagent with said third reagent, a resulting mixture containing at least 35 millimolar concentration of aspartate, from about 0.2 to about 35 millimolar concentration of 2-oxoglutarate, from about 0.5 to about 5 millimolar concentration of reduced NADH, at least 175 units/liter of LDH and at least 140 units/liter of MDH and upon direct mixing of, said second reagent with said third reagent, to provide a resulting mixture containing at least 130 millimolar alanine, from about 0.2 to about 35 millimolar concentration of 2-oxoglutarate, from about 0.5 to about 5 millimolar concentration of reduced NADH, at least 175 units/liter of LDH and at least 140 units/liter of MDH.
Claim 3
Dependent Claim 31 words
The kit of claim 1 wherein sufficient pyridoxal phosphate is present in said third reagent to reactivate substantially all apo-transaminase in a sample of body fluid tested for total transaminase activity.
Claim 4
Dependent Claim 11 words
The kit of claim 1 wherein said third reagent is lyophilized.

References Cited (Backward Citations)

US3458403A Cited
US3953294A Cited
US4024021A Cited
US4086142A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1983-11-25 1984-05-26 1984-11-25 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1987-11-25 1988-05-26 1988-11-25 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1991-11-25 1992-05-26 1992-11-25 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag